Recurrent and consecutive non-arteritic optic neuropathy in a patient with protein S deficiency by Wong, IYH et al.
Title Recurrent and consecutive non-arteritic optic neuropathy in apatient with protein S deficiency
Author(s) Wong, IYH; Koo, SCY; Chan, CWN
Citation Hong Kong Medical Journal, 2010, v. 16 n. 6, p. 480-483
Issued Date 2010
URL http://hdl.handle.net/10722/132809
Rights Hong Kong Medical Journal. Copyright © Hong Kong Academyof Medicine Press.
480	 Hong	Kong	Med	J		Vol	16	No	6	#	December	2010	#		www.hkmj.org
Case report
In August 2009, a 55-year-old Chinese man with a history of protein S deficiency presented 
to the Department of Ophthalmology, Tung Wah Eastern Hospital, Hong Kong, with a 
painless inferior visual field defect in his right eye since waking that morning. Protein S 
deficiency was diagnosed 10 years previously following recurrent episodes of deep vein 
thrombosis, which was treated by warfarin to maintain his international normalised ratio 
(INR) in the range of 2.0 to 2.5. He did not have thrombotic episodes, and control of his 
condition was satisfactory with no recurrence of thrombosis after initiation of warfarin. 
He did not smoke.
 Examination at presentation showed best-corrected visual acuity of 20/50 in the right 
eye and 20/30 in the left eye. A visual field defect was found in the right eye, involving the 
temporal field, as shown in Figures 1 and 2. He also had a right afferent pupillary defect 
(APD) and dyschromatopsia. The right optic disc was crowded, hyperaemic, and swollen 
with blurred margins, and there was a splinter haemorrhage over the nasal side of the 
disc. The left eye visual field and colour vision were normal and the disc did not show any 
abnormalities apart from being crowded. 
 He did not have symptoms suggestive of arteritic optic neuropathy, such as headache, 
jaw claudication, neck pain, temporal fossa tenderness, or other systemic discomfort. 
Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were within the normal 
ranges. Owing to the lack of typical symptoms and the normal ESR/CRP results, giant cell 
arteritis or other arteritic optic neuropathies were thought to be unlikely diagnoses, so 
temporal artery biopsy was not performed. He had no previous episodes and did not have 
symptoms suggestive of multiple sclerosis. He was afebrile. 
 In view of the clinical presentation, history of thrombophilia, characteristic visual 
field defect, and a crowded swollen hyperaemic disc, non-arteritic ischaemic optic 
neuropathy (NAION) in the right eye was diagnosed. Apart from the total cholesterol level 
approaching the upper limit of normal range (5.0 mmol/L; reference level, <5.17 mmol/L), 
blood tests for other risk factors did not demonstrate significant abnormalities, and his 
blood pressure was normal. Magnetic resonance imaging (MRI) was performed to exclude 
compressive lesions and intracranial pathology. 
 Initially, the causative factor was thought to be thrombophilia and a haematologist 
was involved in the management. The patient was taking warfarin with a target INR of 1.5 
to 2.0. His INR at presentation was 1.9. In view of the possible association of thrombophilia 
with NAION, the warfarin dose was increased from 3.5 mg to 4.0 mg, and the target INR 
was increased to 2.0 to 2.5. An INR of 2.3 was achieved within 7 days. Apart from redefining 
the target INR, a conservative approach to management was adopted, which proved to be 
successful initially. His condition improved and the visual function (pupil response, visual 
acuity, colour vision) in his right eye returned to near normal within 7 days. On day 7, the 
visual acuity in his right eye was 20/25 and the left eye remained at 20/30. 
 On day 11, he presented with bilateral visual deterioration on waking, which was 
worse on the left side. His visual acuity was 20/100 in the right eye and counting fingers 
in the left eye. Pupil reaction was sluggish bilaterally, but was worse on the left side 
Recurrent and consecutive non-arteritic optic 
neuropathy in a patient with protein S deficiency
C A S E
R E P O R T
Key words
Arteritis; Blood protein; Optic 
neuropathy, ischemic; Thrombophilia; 
Vision disorders
Hong Kong Med J 2010;16:480-3
Department of Ophthalmology, Tung 
Wah Eastern Hospital, Causeway Bay, 
Hong Kong
IYH Wong*, MRCS(Ed) 
SCY Koo, FHKAM (Ophthalmology) 
CWN Chan, FHKAM (Ophthalmology) 
* IYH Wong is now with the Eye Institute, 
University of Hong Kong.
Correspondence to: Dr IYH Wong
Email: ianyhwong@gmail.com
Ian YH Wong
Simon CY Koo
Clement WN Chan
王逸軒
顧智仁
陳偉能
A 50-year-old man with a history of protein S deficiency treated by long-term warfarin 
presented with right non-arteritic optic neuropathy. Following successful augmentation of 
warfarin to minimise the effect of thrombophilia, he had a recurrence in the right eye and 
involvement of the left eye 11 days after the initial onset. Further investigation showed a 
marginal blood lipid profile, which was treated with lipid-lowering agents. A combination 
of aetiologies was seen in this patient. Other unique factors, such as the short duration to 
recurrence and involvement of the fellow eye, are discussed. 
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cholesterol 5.0 mmol/L, low-density lipoprotein (LDL) 
3.12 mmol/L (reference range, 1.55-3.37 mmol/L), high-
density lipoprotein 1.01 mmol/L (reference range, 
0.91-1.68 mmol/L), and triglycerides 1.88 mmol/L 
(reference range, 0.11-2.15 mmol/L). His INR was 2.2. 
 After consultation with the haematologist, 
a further increase of warfarin was thought to 
predispose the patient to a risk of haemorrhage, and 
was not likely to produce a beneficial effect since a 
recurrence and consecutive NAION occurred despite 
a successful increase in INR during the previous week. 
一名因有蛋白S缺乏症而長期接受華法林（warfarin）藥物治療的50歲
男性，病發時右眼出現非動脈性視神經病變。為把易栓症的影響減至
最低，加強了病人服用華法林的劑量，可是他的右眼再次出現非動脈
性視神經病變。首次病發的11天後，病人的左眼亦受牽連。進一步調
查顯示病人的血脂形態呈邊際水平，遂施以降血脂肪劑。這名病人病
發時出現多種症狀。本文亦會討論有關非動脈性視神經病變的特徵，
包括復發期短及牽連另一只眼。
一名蛋白S缺乏症患者出現復發性及連續
發生的非動脈性視神經病變
with a weakly positive left APD. Dyschromatopsia 
was positive bilaterally. Humphrey visual field test 
showed an inferior visual field defect in the right eye 
and a gross visual field defect in the left eye. There 
was no interval change in the appearance of the right 
disc, but the left disc was hyperaemic and swollen 
with blurred margins, and a splinter haemorrhage 
was noted inferiorly. The impression was recurrent 
NAION in the right eye and consecutive NAION in 
the left eye.
 Repeated blood pressure values and blood 
tests—including immune markers, fasting glucose, 
Venereal Disease Research Laboratory, complete 
blood count, and liver and renal function—were 
all within the normal range. Lipid profile was 
approaching upper limit of normal range, ie total 
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FIG 1. Humphrey visual field progression over time
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FIG 2. Disc photos of (a) the swollen right disc on day 1, with a nasal splinter 
haemorrhage, hyperaemia, and blurred margins; (b) the swollen left disc on day 11 
with an inferior splinter haemorrhage, hyperaemia, and blurred margins; (c) the right 
disc and (d) left disc on day 90 showing resolution of the splinter haemorrhage and 
swelling, leaving disc pallor.  The right disc shows temporal sectoral pallor, whereas the 
left disc shows diffuse pallor. Both discs are structurally crowded
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A combined aetiology, rather than thrombophilia 
alone, was suspected. An effort was made to optimise 
his blood lipid profile to prevent further exacerbation 
of the condition. Atorvastatin 10 mg daily was started 
and, within 2 weeks, his total cholesterol decreased 
to 2.9 mmol/L, LDL to 1.45 mmol/L, and triglycerides 
to 0.96. Aspirin was considered, but after discussion 
with the haematologist it was deemed unnecessary 
because he was already taking warfarin, and there 
might not have been any added benefits from aspirin. 
 His condition stabilised and visual function 
recovered bilaterally, first in the right eye and then 
the left eye, with no further recurrences at his latest 
follow-up 4 months after the initial presentation.
Discussion
Non-arteritic ischaemic optic neuropathy is fairly 
commonly seen by general practitioners and 
ophthalmologists. The condition mimics other 
conditions presenting with sudden painless visual 
loss. Non-arteritic ischaemic optic neuropathy is 
caused by a partial or total infarction of the optic 
nerve head from occlusion of the short posterior 
ciliary arteries.1 Classically, NAION occurs as an 
isolated event and affects middle-aged and elderly 
people. Predisposing factors include hypertension, 
diabetes, hypercholesterolaemia, collagen vascular 
disease, antiphospholipid antibody syndrome, 
sudden hypotensive events, and cataract surgery.1 
 Non-arteritic ischaemic optic neuropathy 
typically presents with sudden painless unilateral 
visual loss on waking, and involves the inferior 
half of the visual field more than the superior 
half. Vision loss ranges from mild impairment to 
light perception only, and colour vision defect is 
proportional to vision loss. The pupil response varies 
from near normal to APD, and usually correlates 
with other findings. In the acute stage, a typical disc 
is hyperaemic with swollen margins, and may have 
splinter haemorrhages. A chronic or resolved disc 
is pale and either diffuse or sectoral corresponding 
to the nerve fibre damage. Important differential 
diagnoses include optic neuritis, association with 
multiple sclerosis, compressive optic neuropathy, 
and arteritic anterior ischaemic optic neuropathy, 
although the list is endless. 
 For optic neuritis, the presentation is classically 
acute unilateral painless visual loss in a young woman 
with a history of multiple sclerosis. There is usually 
APD and the disc is usually hyperaemic and swollen. 
The visual field defect is commonly diffuse. The 
atypical age and sex, and lack of history of multiple 
sclerosis or plaques on MRI of the brain reduced 
the likelihood of a diagnosis of optic neuritis for 
this patient. Compressive optic neuropathies can 
present at any age, and vision loss is more gradual. 
Pupil response can be normal. Disc swelling is 
diffuse in the acute stage, but the disc can be pale 
in the chronic stage. Classically, optociliary shunts 
can be seen on the disc surface. Common aetiologies 
include optic nerve sheath meningioma and optic 
nerve glioma. The bilaterality and acute presentation 
of this patient made this diagnosis unlikely. Arteritic 
anterior ischaemic optic neuropathy typically occurs 
in older women with giant cell arteritis. Classically, 
there is dramatic vision loss associated with APD, jaw 
claudication, temporal fossa pain, and neck pain. The 
disc is classically chalky white and swollen. Bilateral 
involvement is common and urgent temporal artery 
biopsy is required for suspected cases. The lack 
of typical symptoms and age mismatch made this 
diagnosis unlikely. A rare differential diagnosis is 
Leber’s hereditary optic neuropathy (LHON), which 
is a mitochondrial disease typically seen in young 
men in their twenties, with sudden loss of vision in 
one eye followed by involvement of the fellow eye 
in the next days or weeks. The vision usually remains 
poor (can be <6/60) in the long term. For this patient, 
this was a diagnosis of exclusion, but in view of the 
more likely diagnosis of NAION, further examination 
for LHON was deemed unnecessary. 
 This patient most likely had an episode of 
NAION in the right eye followed by a rapid recovery, 
and subsequently had a recurrence in the right eye 
together with a first episode in the left eye. 
 Apart from structurally crowded discs, 
protein S deficiency and hyperlipidaemia may have 
contributed to the development of an ischaemic 
optic neuropathy. According to a report by Salomon 
et al,2 thrombophilia is not positively associated with 
NAION, as the high-flow rate within the arteries 
makes them less prone to developing microemboli. 
However, a report by Kuhli-Hattenbach et al3 found 
a high prevalence of thrombophilia among patients 
with NAION population. In this patient, after the first 
episode of NAION, the target INR was raised, but this 
failed to prevent the recurrence. Therefore, other 
aetiologies were likely to be involved. 
 While structurally crowded optic nerve 
heads are inborn and cannot be changed, the only 
other preventable risk factor was hyperlipidaemia. 
Atorvastatin was started after the recurrence and 
involvement of the fellow eye to minimise this risk 
factor. Following successful lowering of the patient’s 
total cholesterol from 5.0 mmol/L to 2.9 mmol/L, 
his condition stabilised and improved gradually 
without further recurrences. This suggests that 
hyperlipidaemia was likely to be responsible for 
inducing the condition, in addition to a possible 
contribution from thrombophilia. This is in agree-
ment with the report by Deramo et al,4 which supports 
the finding that NAION may be the initial presentation 
in a young patient with a raised lipid profile. 
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 A peculiar feature in this patient was the short 
period to the involvement of the fellow eye. In a report 
by Newman et al,5 the interval to the involvement of 
the fellow eye ranged from 2 weeks to 22 years. In this 
patient, the interval between the first episode in the 
right eye to the occurrence in the left eye was only 
11 days, which is shorter than the shortest interval 
reported.5
 Another unusual feature was the recurrence of 
NAION in the right eye. According to the textbooks, 
NAION does not recur.6 In this patient however, 
NAION clearly did recur, as demonstrated by the 
visual field progression, which is in agreement 
with other reports.7 In a report by Hayreh et al,7 
recurrence of NAION was found in 6.4% of 829 eyes. 
However, thrombophilia and hyperlipidaemia were 
not mentioned to be associated with recurrence of 
NAION. In our patient, a combination of aetiologies 
may have contributed to the recurrence seen in the 
right eye. A possible explanation is that during the 
first insult, the ischaemic interval was so transient that 
reperfusion took place before irreversible damage 
occurred. As the causative factor was not corrected, a 
recurrence occurred within a short period. 
 In another report, improvement in visual 
function may be seen up to 6 months after the initial 
NAION attack.8 As it is only 4 months after the onset 
for this patient, there is still time for progress and 
more improvement may occur in the future. In the 
meantime, the target INR remains 2.0 to 2.5 and 
his cholesterol is kept low to provide an optimum 
environment for the optic nerve to regain its function.
 For any patient with NAION, even with an 
apparent cause (protein S deficiency in this patient), 
other underlying confounding factors should still be 
sought. 
